Changhai Hospital
Clinical trials sponsored by Changhai Hospital, explained in plain language.
-
Engineered immune cells take on kidney disease in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called anti-CD19/BCMA universal CAR T cells (KN3601) for people with relapsed or refractory immune-mediated kidney disease. The therapy involves collecting a patient's immune cells, engineering them to target and destroy harmful B cell…
Phase: EARLY_PHASE1 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
New hope for chemo patients: drug may prevent dangerous drop in platelets
Disease control Recruiting nowThis study tests whether the drug hetrombopag can prevent low platelet counts caused by chemotherapy in people with gastrointestinal cancers like stomach or colon cancer. About 40 participants will take the drug daily for 14 days after each chemo cycle. The goal is to keep platel…
Phase: PHASE2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 22, 2026 12:08 UTC
-
Gut bacteria swap could fight pancreatitis infections
Disease control Recruiting nowThis study tests whether transplanting healthy gut bacteria (FMT) can reduce serious infections in people with moderate to severe acute pancreatitis. About 80 adults will receive either FMT or a placebo. The goal is to see if FMT lowers the risk of infected pancreatic tissue, sep…
Phase: NA • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
Freeze and fight: new combo therapy aims to save bladders in High-Risk cancer
Disease control Recruiting nowThis study tests a new approach to treat high-risk bladder cancer without removing the bladder. It combines freezing the tumor during surgery with immunotherapy and low-dose chemotherapy. The goal is to see if this combination can help patients live longer and keep their bladder,…
Phase: NA • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 18, 2026 11:49 UTC
-
Engineered immune cells take on pancreatic cancer in early trial
Disease control Recruiting nowThis early-stage study tests a new treatment called CAR-NK cells (CL-NK-003) in 9 people with advanced pancreatic cancer that has not responded to standard therapies. The main goal is to check safety and find the right dose. Researchers will also watch for signs that the treatmen…
Phase: PHASE1 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
Universal CAR-T cells take on lupus and more in early trial
Disease control Recruiting nowThis early-phase study tests a new type of CAR-T cell therapy (called KN3601) for people with severe autoimmune diseases like lupus, scleroderma, Sjögren's syndrome, rheumatoid arthritis, and vasculitis that haven't responded to standard treatments. The therapy uses specially eng…
Phase: EARLY_PHASE1 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Personalized cell therapy targets tough pancreatic cancer
Disease control Recruiting nowThis study tests a new treatment for people with advanced pancreatic cancer that has a specific genetic change (KRAS G12V). The treatment uses the patient's own immune cells, modified in a lab to better recognize and attack cancer cells. The goal is to see if this therapy is safe…
Phase: PHASE1, PHASE2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Bladder cancer breakthrough? new combo aims to save bladders
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug toripalimab to standard BCG treatment can stop high-risk bladder cancer from returning after surgery. About 31 adults with aggressive non-muscle-invasive bladder cancer will receive the combination for 6 months. The goal is t…
Phase: PHASE2 • Sponsor: Changhai Hospital • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
AI could slash unnecessary pancreatic surgeries, new trial shows
Diagnosis Recruiting nowThis study tests an artificial intelligence system that reads contrast-enhanced CT scans to help doctors decide the best course of action for pancreatic diseases. The AI sorts patients into three groups: need treatment, need close monitoring, or routine follow-up. Researchers aim…
Sponsor: Changhai Hospital • Aim: Diagnosis
Last updated Jun 18, 2026 11:50 UTC
-
Poop pills may stop deadly infections in pancreatitis patients
Prevention Recruiting nowThis study tests whether fecal microbiota transplantation (FMT) can prevent serious infections in people with moderately severe or severe acute pancreatitis. About 150 adults will receive either FMT or a placebo through a feeding tube. The goal is to see if FMT lowers the chance …
Phase: NA • Sponsor: Changhai Hospital • Aim: Prevention
Last updated Jun 22, 2026 12:05 UTC
-
New combo approach aims to stop pancreatitis after stone treatment
Prevention Recruiting nowThis study tests whether giving extra IV fluids along with a standard anti-inflammatory suppository can better prevent pancreatitis after a procedure to break up pancreatic stones. About 1250 adults with chronic pancreatitis will be randomly assigned to receive either the combina…
Phase: NA • Sponsor: Changhai Hospital • Aim: Prevention
Last updated Jun 22, 2026 11:58 UTC
-
Lower dose, same protection? new trial aims to prevent ERCP pancreatitis
Prevention Recruiting nowThis study tests whether a lower dose (50mg) of rectal indomethacin works as well as the standard dose (100mg) to prevent pancreatitis after an ERCP procedure. About 1,366 adults scheduled for ERCP will be randomly assigned to receive either dose 30 minutes before the procedure. …
Phase: PHASE4 • Sponsor: Changhai Hospital • Aim: Prevention
Last updated Jun 15, 2026 18:56 UTC
-
New diet could make colonoscopy prep less miserable for IBD patients
Symptom relief Recruiting nowThis study tests whether a pre-packaged low-residue nutrition formula (Maifu Changqing®) can improve bowel cleanliness and comfort during colonoscopy preparation for 1,000 adults with inflammatory bowel disease (IBD). Participants will be randomly assigned to receive either the s…
Phase: NA • Sponsor: Changhai Hospital • Aim: Symptom relief
Last updated Jun 16, 2026 12:55 UTC
-
New diet could simplify colonoscopy prep for IBD patients
Symptom relief Recruiting nowThis study tests whether a pre-packaged low-residue diet (Maifu Changqing®) helps people with inflammatory bowel disease (IBD) prepare for colonoscopy more comfortably and effectively. About 500 adults with IBD will be enrolled across multiple hospitals in China. The goal is to s…
Phase: NA • Sponsor: Changhai Hospital • Aim: Symptom relief
Last updated Jun 15, 2026 19:07 UTC
-
New study aims to improve colonoscopy prep for IBD patients
Knowledge-focused Recruiting nowThis study involves 1,000 adults with inflammatory bowel disease (IBD) who need a colonoscopy. Researchers want to see how well current bowel preparation methods work and what factors lead to poor preparation. The goal is to create a tool that predicts which patients might have t…
Sponsor: Changhai Hospital • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:49 UTC
-
New database aims to spot early stomach cancer signs
Knowledge-focused Recruiting nowThis study is gathering images from special cameras and CT scans, along with lab results, to create a database for early upper gastrointestinal cancers and precancerous conditions. About 500 adults who need certain procedures will take part. The goal is to help doctors better rec…
Sponsor: Changhai Hospital • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:04 UTC